Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
Shaowei Zhang, Michiyo Sakuma, Girdhar Singh Deora, et al.
Communications Biology (2019) Vol. 2, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Tryptophan Metabolism as a Pharmacological Target
Morgane Modoux, Nathalie Rolhion, Sridhar Mani, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 1, pp. 60-73
Open Access | Times Cited: 223
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 119
Microbiota metabolites modulate the T helper 17 to regulatory T cell (Th17/Treg) imbalance promoting resilience to stress-induced anxiety- and depressive-like behaviors
Susan Westfall, Francesca Caracci, Danyue Zhao, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 350-368
Open Access | Times Cited: 110
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
Niklas Joisten, Jorge L. Ruas, Nady Braidy, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 10, pp. 946-954
Closed Access | Times Cited: 57
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission (2024) Vol. 131, Iss. 12, pp. 1367-1387
Open Access | Times Cited: 10
Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
Adrian Mor, Bartłomiej Kałaska, Dariusz Pawlak
International Journal of Tryptophan Research (2020) Vol. 13
Open Access | Times Cited: 51
New frontiers in flavin-dependent monooxygenases
Renata A.G. Reis, Hao Li, Maxim Johnson, et al.
Archives of Biochemistry and Biophysics (2021) Vol. 699, pp. 108765-108765
Open Access | Times Cited: 51
Kynurenine Metabolism and Alzheimer’s Disease: The Potential Targets and Approaches
Vivek Sharma, Thakur Gurjeet Singh, Nirbhay Kumar Prabhakar, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1459-1476
Closed Access | Times Cited: 28
The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases
Xuepeng Bian, Qian Wang, Yibing Wang, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 6
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects
Luana de Fátima Alves, J. Bernadette Moore, Douglas B. Kell
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9082-9082
Open Access | Times Cited: 6
Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases
Tharmarajan Ramprasath, Young‐Min Han, Donghong Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36
The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives
Katarzyna Ciapała, Joanna Mika, Ewelina Rojewska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11055-11055
Open Access | Times Cited: 35
Identification of potent inhibitors of kynurenine-3-monooxygenase from natural products: In silico and in vitro approaches
Redouane Rebai, Miguel Carmena‐Bargueño, Mohammed Esseddik Toumi, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30287-e30287
Open Access | Times Cited: 5
Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
Mary E.W. Collier, Shaowei Zhang, Nigel S. Scrutton, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 6, pp. 1473-1481
Open Access | Times Cited: 29
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases
Hualiang Shen, Xinde Xu, Yalong Bai, et al.
European Journal of Medicinal Chemistry (2023) Vol. 251, pp. 115258-115258
Closed Access | Times Cited: 12
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy
Trevor W. Stone, L. Gail Darlington, Abdulla A.‐B. Badawy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9040-9040
Open Access | Times Cited: 4
Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials
Kelly Jimin Park, Yao Gao
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 4
Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
Filipe B. Rodrigues, Lauren M. Byrne, Alexander J. Lowe, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 2, pp. 539-553
Open Access | Times Cited: 26
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders
Michael Y. Bai, David B. Lovejoy, Gilles J. Guillemin, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 1-2, pp. 19-33
Open Access | Times Cited: 25
Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression
Yanmei Chen, Jiahui Zhang, Yueying Yang, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 12, pp. 4339-4355
Closed Access | Times Cited: 18
A palette of fluorophores that are differentially accumulated by wild-type and mutant strains of Escherichia coli: surrogate ligands for profiling bacterial membrane transporters
J. Enrique Salcedo-Sora, Srijan Jindal, Steve O’Hagan, et al.
Microbiology (2021) Vol. 167, Iss. 2
Open Access | Times Cited: 22
The tryptophan metabolism, kynurenine pathway and oxidative stress – implications for glioma pathobiology
Marta Obara‐Michlewska
Neurochemistry International (2022) Vol. 158, pp. 105363-105363
Closed Access | Times Cited: 16
Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
Marie K. Bondulich, Yilan Fan, Yeojin Song, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Nutrient Metabolites Associated With Low D3Cr Muscle Mass, Strength, and Physical Performance in Older Men
Megan Hetherington‐Rauth, Eileen Johnson, Eugenia Migliavacca, et al.
The Journals of Gerontology Series A (2023) Vol. 79, Iss. 2
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top